GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan Keqian Biology Co Ltd (SHSE:688526) » Definitions » Marketable Securities

Wuhan Keqian Biology Co (SHSE:688526) Marketable Securities : ¥667.6 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Wuhan Keqian Biology Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Wuhan Keqian Biology Co's Marketable Securities for the quarter that ended in Sep. 2024 was ¥667.6 Mil.

Wuhan Keqian Biology Co's annual Marketable Securities increased from Dec. 2021 (¥213.0 Mil) to Dec. 2022 (¥674.8 Mil) and increased from Dec. 2022 (¥674.8 Mil) to Dec. 2023 (¥745.0 Mil).


Wuhan Keqian Biology Co Marketable Securities Historical Data

The historical data trend for Wuhan Keqian Biology Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Keqian Biology Co Marketable Securities Chart

Wuhan Keqian Biology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial - 270.00 212.95 674.83 745.04

Wuhan Keqian Biology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 910.04 745.04 695.12 645.32 667.65

Wuhan Keqian Biology Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Wuhan Keqian Biology Co  (SHSE:688526) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Wuhan Keqian Biology Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Wuhan Keqian Biology Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Keqian Biology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 419, Gaoxin 2nd Road, Donghu New Technology Development Zone, Hubei Province, Wuhan, CHN, 430073
Wuhan Keqian Biology Co Ltd is engaged in research and development, production, sales and animal epidemic prevention technical services of veterinary biological products. The company's products include Combination plan; Vaccine for swine; Poultry vaccine; Pet vaccine; and Diagnostic reagent.
Executives
Ye Zhang Fa Supervisors
Hao Gen Xi Core technical personnel
Zhang Hua Wei Core technical personnel
Zhou Ming Guang Core technical personnel
Zou Tian Tian senior management
Xu Gao Yuan Director
Chen Guan Ping Director

Wuhan Keqian Biology Co Headlines

No Headlines